Clinical Practice Guideline

Guidelines in Development

September 17, 2021

Listed below are the current guidelines and updates in development. Topics are prioritized for development by the Clinical Guidelines Committee. During the development process, guidelines are made available for open comment to identify any errors or gaps in the draft guideline prior to publication to ensure greater transparency. Check back here for opportunities to submit topics for consideration and to review guidelines open for comment when available. To learn more about the Endocrine Society guideline development process, access the guideline development methodology page.  


Management of Individuals with Diabetes at High-Risk for Hypoglycemia

Anticipated Publication: Summer 2022
This guideline will update the diabetes-specific portions of the 2009 Evaluation and Management of Adult Hypoglycemic Disorders: Endocrine Society Clinical Practice Guideline, and address developing issues surrounding hypoglycemia in both adults and children living with diabetes.

Public Comment Period: Submit your comments.

The Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings

Anticipated Publication: Summer 2022
This is an update to the 2012 guideline.  It will provide recommendations for the non-critically ill hospitalized patient population with diabetes or with newly recognized or stress induced hyperglycemia.  

Public Comment Period: Closed

Malignant Hypercalcemia

Anticipated Publication: Summer 2022
This new guideline will provide recommendations for patients with hypercalcemia of malignancy or hypercalcemia due to parathyroid carcinoma.

Vitamin D

Anticipated Publication: Summer 2023
This is an update to the 2011 guideline.

Diabetes in Pregnancy

Anticipated Publication: Spring 2024
This guideline is a collaboration with the European Society of Endocrinology.

The Management of Primary Aldosteronism

Anticipated Publication: Spring 2024
This is an update to the 2016 guideline.


Retired Guidelines

Endocrine Society guidelines can be retired for any of the following reasons: the guideline as a whole is sufficiently out of date that it is no longer relevant to clinical practice; one or more of the guideline recommendations contain important inaccuracies or omissions that, if followed precisely, could lead to substandard patient care or potential harm; or the guideline has been replaced by a more recent publication.

Last Updated:

CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Clinical Practice Guidelines

CPG Pocket Guides

Clinical Practice Guidelines Pocket Guides
Practical quick-reference tools to help you make accurate clinical decisions at the point of care.
Clinical Practice Guidelines

CPG Pocket Guides

Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.